Nadler Financial Group, Inc. Amgen Inc Transaction History

Nadler Financial Group, Inc.

$850 Million
Q2 2024

A detailed history of Nadler Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nadler Financial Group, Inc. holds 1,456 shares of AMGN stock, worth $484,047. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,456

Previous 1,451 0.34%

Holding current value

$484,047

Previous $412,000 10.19%

% of portfolio

0.05%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $1,313 - $1,596	5 Added 0.34%	1,456 $454,000
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.35%	1,451 $412,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $1,534 - $1,730	6 Added 0.42%	1,446 $416,000
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $1,311 - $1,628	6 Added 0.42%	1,440 $387,000
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $1,499 - $1,773	7 Added 0.49%	1,434 $318,000
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $1,580 - $1,926	7 Added 0.49%	1,427 $344,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $1,145 - $1,455	5 Added 0.35%	1,420 $372,000
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $448 - $506	-2 Reduced 0.14%	1,415 $319,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $2,537 - $2,824	11 Added 0.78%	1,417 $345,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $14,691 - $16,252	-67 Reduced 4.55%	1,406 $340,000
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $1,193 - $1,365	6 Added 0.41%	1,473 $331,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $1,273 - $1,492	6 Added 0.41%	1,467 $312,000
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $1,167 - $1,295	5 Added 0.34%	1,461 $356,000
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $1,109 - $1,293	5 Added 0.34%	1,456 $362,000
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $1,081 - $1,288	5 Added 0.35%	1,451 $334,000
Q3 2020 Oct 07, 2020	BUY	$234.65 - $260.95 $938 - $1,043	4 Added 0.28%	1,446 $368,000
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $989 - $1,213	5 Added 0.35%	1,442 $340,000
Q1 2020 Apr 09, 2020	BUY	$182.24 - $241.7 $911 - $1,208	5 Added 0.35%	1,437 $291,000
Q4 2019 Jan 08, 2020	BUY	$189.21 - $243.2 $756 - $972	4 Added 0.28%	1,432 $345,000
Q3 2019 Oct 03, 2019	SELL	$174.11 - $208.62 $86,010 - $103,058	-494 Reduced 25.7%	1,428 $276,000
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $24,671 - $28,920	148 Added 8.34%	1,922 $354,000
Q1 2019 Apr 04, 2019	BUY	$180.87 - $203.88 $1,446 - $1,631	8 Added 0.45%	1,774 $337,000
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $1,248 - $1,457	7 Added 0.4%	1,766 $344,000
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $1,297 - $1,462	7 Added 0.4%	1,759 $365,000
Q2 2018 Jul 10, 2018	BUY	$166.05 - $186.51 $36,863 - $41,405	222 Added 14.51%	1,752 $323,000
Q1 2018 Apr 05, 2018	SELL	$169.43 - $198.0 $11,521 - $13,464	-68 Reduced 4.26%	1,530 $261,000
Q4 2017 Jan 12, 2018	BUY	$168.79 - $188.59 $1,012 - $1,131	6 Added 0.38%	1,598 $278,000
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $266,325 - $304,072	1,592	1,592 $297,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.

Account

Nadler Financial Group, Inc. Amgen Inc Transaction History